The Addition of Thalidomide to the Induction Treatment of Newly Presenting Myeloma Patients Increases the CR Rate Which Is Likely to Translate Into Improved PFS and OS

Full text for this publication is not currently held within this repository. Alternative links are provided below where available.

Author(s): Morgan GJ, Davies FE, Gregory WM, Bell SE, Szubert AJ, Cocks K, Coy NN, Drayson MT, Owen RG, Ross FM, Jackson GH, Child JA

Publication type: Conference Proceedings (inc. Abstract)

Publication status: Published

Conference Name: Blood: 51st Annual Meeting of the American Society of Hematology

Year of Conference: 2009

Pages: 149 no. 352

ISSN: 0006-4971

Publisher: American Society of Hematology

URL: http://abstracts.hematologylibrary.org/cgi/content/abstract/114/22/352

Library holdings: Search Newcastle University Library for this item

ISBN: 15280020

ePrints